120 related articles for article (PubMed ID: 8530517)
1. LLC-PK1 cell growth is repressed by WT1 inhibition of G-protein alpha i-2 protooncogene transcription.
Kinane TB; Finder JD; Kawashima A; Brown D; Abbate M; Fredericks WJ; Sukhatme VP; Rauscher FJ; Ercolani L
J Biol Chem; 1995 Dec; 270(51):30760-4. PubMed ID: 8530517
[TBL] [Abstract][Full Text] [Related]
2. Growth of LLC-PK1 renal cells is mediated by EGR-1 up-regulation of G protein alpha i-2 protooncogene transcription.
Kinane TB; Finder JD; Kawashima A; Brown D; Abbate M; Shang C; Fredericks WJ; Rauscher FJ; Sukhatme VP; Ercolani L
J Biol Chem; 1994 Nov; 269(44):27503-9. PubMed ID: 7961665
[TBL] [Abstract][Full Text] [Related]
3. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.
Nakagama H; Heinrich G; Pelletier J; Housman DE
Mol Cell Biol; 1995 Mar; 15(3):1489-98. PubMed ID: 7862142
[TBL] [Abstract][Full Text] [Related]
4. The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest.
Sells SF; Muthukumar S; Sukhatme VP; Crist SA; Rangnekar VM
Mol Cell Biol; 1995 Feb; 15(2):682-92. PubMed ID: 7823937
[TBL] [Abstract][Full Text] [Related]
5. cAMP regulates G-protein alpha i-2 subunit gene transcription in polarized LLC-PK1 cells by induction of a CCAAT box nuclear binding factor.
Kinane TB; Shang C; Finder JD; Ercolani L
J Biol Chem; 1993 Nov; 268(33):24669-76. PubMed ID: 8227026
[TBL] [Abstract][Full Text] [Related]
6. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
7. Repression of the c-myb gene by WT1 protein in T and B cell lines.
McCann S; Sullivan J; Guerra J; Arcinas M; Boxer LM
J Biol Chem; 1995 Oct; 270(40):23785-9. PubMed ID: 7559553
[TBL] [Abstract][Full Text] [Related]
8. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
[TBL] [Abstract][Full Text] [Related]
9. In situ expression of the early growth response gene-1 during murine nephrogenesis.
Rackley RR; Kessler PM; Campbell C; Williams BR
J Urol; 1995 Aug; 154(2 Pt 2):700-5. PubMed ID: 7609158
[TBL] [Abstract][Full Text] [Related]
10. Effects of Denys-Drash syndrome point mutations on the DNA binding activity of the Wilms' tumor suppressor protein WT1.
Borel F; Barilla KC; Hamilton TB; Iskandar M; Romaniuk PJ
Biochemistry; 1996 Sep; 35(37):12070-6. PubMed ID: 8810912
[TBL] [Abstract][Full Text] [Related]
11. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
12. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
McCoy C; McGee SB; Cornwell MM
Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
[TBL] [Abstract][Full Text] [Related]
13. Transcription of the dominant-negative helix-loop-helix protein Id1 is regulated by a protein complex containing the immediate-early response gene Egr-1.
Tournay O; Benezra R
Mol Cell Biol; 1996 May; 16(5):2418-30. PubMed ID: 8628310
[TBL] [Abstract][Full Text] [Related]
14. High affinity binding sites for the Wilms' tumour suppressor protein WT1.
Hamilton TB; Barilla KC; Romaniuk PJ
Nucleic Acids Res; 1995 Jan; 23(2):277-84. PubMed ID: 7862533
[TBL] [Abstract][Full Text] [Related]
15. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
[TBL] [Abstract][Full Text] [Related]
16. Physical and functional interaction between the HCMV IE2 protein and the Wilms' tumor suppressor WT1.
Kim JM; Hong Y; Semba K; Kim S
Biochem Biophys Res Commun; 2000 Jan; 267(1):59-63. PubMed ID: 10623574
[TBL] [Abstract][Full Text] [Related]
17. Sp1 is a critical regulator of the Wilms' tumor-1 gene.
Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP
J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935
[TBL] [Abstract][Full Text] [Related]
18. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation.
Stanhope-Baker P; Williams BR
J Biol Chem; 2000 Dec; 275(49):38139-50. PubMed ID: 10973960
[TBL] [Abstract][Full Text] [Related]
19. The Wilms' tumor gene product WT1 activates or suppresses transcription through separate functional domains.
Wang ZY; Qiu QQ; Deuel TF
J Biol Chem; 1993 May; 268(13):9172-5. PubMed ID: 8486616
[TBL] [Abstract][Full Text] [Related]
20. A ternary complex factor-dependent mechanism mediates induction of egr-1 through selective serum response elements following antigen receptor cross-linking in B lymphocytes.
McMahon SB; Monroe JG
Mol Cell Biol; 1995 Feb; 15(2):1086-93. PubMed ID: 7823924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
